Henry Schein to offer Abaxis POC (point-of-care) blood analysers in the US
This article was originally published in Clinica
Point-of-care blood analysis systems developer Abaxis has clinched a distribution deal with Henry Schein, said to be the largest provider of healthcare products to office-based doctors in the combined North American and European markets. Under the terms of the agreement, Henry Schein's medical group will sell Abaxis' full range of human reagent rotors and its Piccolo chemistry analyser in the US. By leveraging its new distributors' significant customer base, Abaxis expects to see an increase in the installed base for its Piccolo system, which, in turn, will drive consumer rotor sales, said the Union, City, California company.